NU E Power Corp. (CSE: NUE) (OTC Pink: NUEPF) ("NUE" or the "Company") is pleased to announce today that two milestones under ...

Johnson & Johnson said a Phase 3 study of its treatment for the autoantibody disease generalized myasthenia gravis showed more than two years of improvements for patients. The pharmaceutical and ...

As published in The Lancet and presented at AAN, NIMBLE trial met its primary and key secondary endpoints at week 24, demonstrating potential best-in-class efficacy and convenience in gMG ...

Johnson & Johnson (NYSE:JNJ) has reported new data from its Phase 3 Vivacity-MG3 trial showing that its therapy IMAAVY ...

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with ...

Construction on the new Wasatch County administration building is underway. Next up: a three-phased Wasatch County jail upgrade.

Oral semaglutide lowered HbA1c vs placebo in a phase 3 trial in adolescents with type 2 diabetes, pending full data and ...

Toshiba begins engineering sample shipments of the AEC-Q100 compliant TB9M030FG, a new addition to the SmartMCD series, ...

Electrochemically exfoliated graphene directs nickel foam surfaces toward gamma-NiOOH during oxygen evolution, improving ...

Patient screening to begin this monthDURHAM, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic ...

Last patient visits for both OCS-01 Phase 3 DIAMOND trials (total 800+ patients) are complete, with topline results expected in June 2026A non-invasive topical treatment for diabetic macular edema ...

Deals: Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, including $3.25 billion ...